272bio Limited
- Small
- Active
- 6 years
- 13 employees
- £3,532,408 (assets)
- Real address
- 5 directors
- 1 owner
- Regular importer
Two conditions of three:
1.Turnover < £10.2 million
2.Balance sheet total < £5.1 million
3.Average number of employees < 50
Field of Operation
Website
Social media
Summary
272bio Ltd, based in Reading, UK, is a small, active company founded five years ago. It employs thirteen people and holds £3,532,408 in assets, with a real address and five directors overseeing operations. The company is owned by Owen Charles Edward. Regular importer of clocks, watches, and their parts (9 months imported), with the last import operation made on January 01, 2024.
The company's website highlights its focus on biotherapeutics for animal health, specifically targeting livestock and companion animal disorders. 272bio leverages innovative technologies to reduce production costs and deliver affordable therapies. It specializes in VHH antibodies—small, flexible biological particles—and offers services including antibody development, cellular and assay technologies, and protein expression and purification. The website emphasizes a large and growing veterinary health market and positions 272bio as a provider of highly effective and specific solutions.
Financially, 272bio Ltd presents a mixed picture. Cash reserves have dramatically increased by 680%, reaching £2,300,000—a significant boost. However, retained earnings and accumulated losses have plummeted by 1000%, resulting in a negative equity of -£2,500,000. Bank borrowings have decreased by 63%, settling at £110,000. Creditors have also increased by 22%, reaching £1,000,000. The company’s investments have increased by 9400%, reaching £1,000,000. The number of employees has increased by 7.7% to fourteen. The company’s small size—meeting two of three criteria for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees—allows for agility, but the substantial equity decline suggests potential challenges. With no auditor mentioned, the figures are unaudited.
The dramatic increase in investments, alongside the negative equity, suggests that 272bio may be burning through money while seeking further funding or expanding its operations. The company's focus on biotechnology and animal health, while promising, also carries inherent risks.
Registered in England/Wales under the registration number 12062536, with a registered address at RG2 9LH, England, Reading, Berkshire, The Gateway Building Collegiate Square, Shinfield.
WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Owners & PSC
-
Individual
- 6 years
- 10
- psc
-
Resident of United Kingdom
Managers
-
Individual
- 9 months
-
Resident of Belgium
-
Individual
- 11 months
-
Resident of Switzerland
-
Individual
- 1 year
-
Resident of United Kingdom
-
Individual
- 2 years
- 1
-
Resident of United Kingdom
-
Individual
- 6 years
- 8
-
Resident of United Kingdom
Last reports
The latest confirmation statement submitted ten months ago.
Last news
-
Total exemption full accounts made up to 2024-06-30Download 9 pages pdf report
-
Appointment of Ms Christine Labeur as a director on 2024-09-13Download 2 pages pdf report
-
Confirmation statement made on 2024-08-24 with updatesDownload 4 pages pdf report
Importer profile by HS codes
Click on the map to see detailed UK statistics on HS code, including companies list.
Last imported products
Click on items to see detailed UK statistics on HS code, including companies list.
Similar importers
- Company names
- HS codes
- Financial data
- Officers and owners
FAQ about 272bio Limited
Looking for leads in the UK?
Try our FREE App—access UK datasets with limited features!